OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
Appropriate analytical assays are needed to determine and ensure that biosimilar critical quality parameters are on track.
Safeguarding against microbial contamination requires rapid detection and innovative technology.
Tools such as manufacturing execution systems, artificial intelligence, and software innovations are useful for enhancing data integrity protection.
Bioanalytical studies are an important aspect of biologic drug development that may necessitate partnering with bioanalysis experts.